Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

NCT04801888 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Influenza

Interventions

BIOLOGICAL: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.
BIOLOGICAL: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 14.

Sponsor

Sinovac Research and Development Co., Ltd.